Erytech pharma
KEY POINTS
Lyon, a leading city in life sciences
BIOPARC LYON, fully dedicated to biotech companies
A 3.4 ha site
40,000 square meters hosting offices and laboratories, a business incubator, technical rooms, a residential complex, support services...
ERYTECH PHARMA
SETS UP A US SUBSIDIARY AND RUN REINFORCES ITS MANAGEMENT TEAM
ased first in the Laënnec company incubator and then in the Adénine Building, Erytech Pharma has grown its international operations and reinforced its commercial development by establishing a US subsidiary in San Francisco.
As a further sign of the company's growth and maturity, Erytech Pharma recently announced the appointment of several highly experienced managers:
-
David Liens (44 years of age, formerly Head of Clinical Development at EUSA-Pharma OPI and International Medical Advisor to Merck) has been appointed as Chief Medical Officer.
-
Philippe Dujardin (formerly Financing & IR Director at Infogrames/Atari and Treasurer at Suez-Lyonnaise des Eaux) has been recruited as Chief Financial Officer.
-
Véronique Sézanne, PharmD, joins the company's Executive Board.
For more information: www.erytech.fr
